A recent study has revealed a possible association between a cholesterol-lowering drug, statins and cure of pre-eclampsia in pregnant women.

As per the report, a team of Scottish scientists is on the verge of probing the potential result of statins to address the percolating concern of rising maternal and infant deaths due to pre-eclampsia.

As per medical experts, pre-eclampsia is a medical condition which leads to high blood pressure, inflammation of the lining of blood vessels, kidney and liver damage and can prove to be fatal for the unborn child. Moreover, doctors believe that the only solution to avert the potential damage of pre-eclampsia in pregnant women is to enforce premature delivery.

If statistics are to be believed, one in every 10 pregnancies are reported as a serious case of pre-eclampsia. Moreover, this study has considered the early theory of using heart-disease drugs to curtail the growth of two proteins that are being held responsible for pre-eclampsia.

Responding to the study, Professor Asif Ahmed, of Edinburgh University’s Centre for Cardiovascular Science, claimed, “If successful this could help provide cheap, widely available therapy against pre-eclampsia which could help reduce maternal and infant deaths across the world”.